| 6050 |
Centers for Disease Control and Prevention |
Html |
en |
Nitroglycerine - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7602 |
Centers for Disease Control and Prevention |
Html |
en |
Drug-Resistant TB |
Centers for Disease Control and Prevention, Division of Tuberculosis Elimination |
| health care provider | 0.380921 |
| multidrug-resistant tb | 0.602688 |
| TB disease | 0.721353 |
| drug-resistant form | 0.379068 |
| Inappropriate management | 0.325431 |
| drug-resistant latent TB | 0.601584 |
| treatment guidelines | 0.32905 |
| potent TB drugs | 0.65757 |
| TB experts | 0.590351 |
| Laboratory Guidance | 0.326313 |
| drug-susceptible TB | 0.5867 |
| drug-resistant TB disease | 0.603811 |
| TB patient receiving | 0.544989 |
| drug-resistant TB experience | 0.60844 |
| MDR TB | 0.765711 |
| TB disease increases | 0.55372 |
| Health care providers | 0.346629 |
| rare type | 0.351312 |
| important way | 0.325792 |
| TB bacteria | 0.658953 |
| disrupts lives | 0.326045 |
| TB treatment | 0.527308 |
| occupational health experts | 0.34495 |
| Mycobacterium tuberculosis strains | 0.349009 |
|
| XDR TB | 0.772281 |
| extensively drug-resistant tb | 0.713536 |
| uncomplicated urinary tract | 0.345339 |
| special concern | 0.326261 |
| people | 0.345756 |
| TB | 0.943155 |
| TB drugs | 0.678776 |
| fluoroquinolone antibacterial drugs | 0.527506 |
| certain uncomplicated infections | 0.344607 |
| proper treatment | 0.333597 |
| XDR TB specimens | 0.589469 |
| injectable second-line drugs | 0.416356 |
| medical provider | 0.341843 |
| drug-resistant TB patients | 0.621417 |
| TB control program | 0.568236 |
| treatment options | 0.350406 |
| state TB control | 0.568266 |
| adverse effects | 0.360962 |
| drug-resistant tb | 0.892555 |
| first-line anti-TB drug | 0.348198 |
| first-line TB drugs | 0.569511 |
| HIV infection | 0.326005 |
| crowded places | 0.326007 |
|
CLICK HERE |
| 7816 |
Centers for Disease Control and Prevention |
Html |
en |
Autism - Health Communication |
Autism - Gateway to Health Communication - CDC |
| early intervention program | 0.582702 |
| long-term support services | 0.572436 |
| significant challenges | 0.44116 |
| life-long developmental disabilities | 0.606685 |
| possible causes | 0.45025 |
| children | 0.453431 |
| main indicator | 0.471895 |
| autism spectrum disorder | 0.978167 |
| health care providers | 0.569756 |
| early signs | 0.709781 |
| brain development | 0.45045 |
| environmental factors | 0.450401 |
| social relationships | 0.441436 |
| Autism spectrum disorders | 0.654536 |
| intellectual development | 0.443859 |
| hometown doctor | 0.569642 |
| Early identification | 0.459426 |
| Megan’s school | 0.492597 |
| United States | 0.458969 |
| Chad | 0.500723 |
| 8-year old son | 0.547935 |
| repetitive behaviors | 0.467215 |
| parental actions | 0.457841 |
| diverse group | 0.441292 |
| Special education services | 0.580381 |
|
| odd behaviors | 0.441454 |
| Chad’s progress | 0.48005 |
| ASD | 0.565691 |
| middle school | 0.441298 |
| social skills groups | 0.556782 |
| physiological symptoms | 0.449813 |
| intensive intervention | 0.454485 |
| social interaction | 0.466028 |
| introspective young artist | 0.562248 |
| physical features | 0.469762 |
| communication skills | 0.469884 |
| great deal | 0.448168 |
| unique challenges | 0.442479 |
| new doctor | 0.445196 |
| Megan | 0.524289 |
| early diagnosis | 0.458283 |
| Chad’s condition | 0.49193 |
| improved functioning | 0.447208 |
| first-time parents | 0.448369 |
| autism conference | 0.477255 |
| IQ levels | 0.465661 |
| eye contact | 0.450098 |
| available medication | 0.444744 |
| little scientific evidence | 0.570323 |
|
CLICK HERE |
| 8339 |
Centers for Disease Control and Prevention |
Html |
en |
TB - Basic TB Facts - TB Personal Stories |
Division of Tuberculosis Elimination |
| TB program Project | 0.770218 |
| health care provider | 0.555242 |
| multidrug-resistant TB | 0.616178 |
| effective care | 0.487291 |
| sole support | 0.476154 |
| contact investigations | 0.46914 |
| Project Juntos | 0.960837 |
| new regimen | 0.475925 |
| completely new course | 0.52239 |
| new TB treatment | 0.661556 |
| health care providers | 0.528159 |
| chest X-ray | 0.471128 |
| skin irritation | 0.467218 |
| binational TB program | 0.786841 |
| TB care | 0.597451 |
| border area | 0.468041 |
| El Paso | 0.468879 |
| good nutritional regimen | 0.521071 |
| Project Juntos staff | 0.525784 |
| TB treatment services | 0.666024 |
| New samples | 0.469454 |
| licensed nurse | 0.479555 |
| lengthy treatment | 0.483317 |
| Project Juntos nurses | 0.635787 |
| local community hospital | 0.545578 |
|
| Texas Department | 0.472843 |
| local TB program | 0.650574 |
| Project Juntos nurse | 0.538537 |
| DSHS Project Juntos | 0.627826 |
| Texas binational TB | 0.783978 |
| single mother | 0.474526 |
| shocking news | 0.476765 |
| TB disease | 0.632067 |
| State Health Services | 0.531055 |
| poorest health centers | 0.55172 |
| standard first-line drugs | 0.524484 |
| persistent night sweats | 0.536336 |
| persistent cough | 0.482979 |
| MDR TB | 0.618115 |
| TB infection | 0.584433 |
| binational patients | 0.480653 |
| special cases—those | 0.470825 |
| TB treatment | 0.700931 |
| new treatment | 0.532204 |
| blood transfusion | 0.469188 |
| elderly mother | 0.4722 |
| TB | 0.891759 |
| program Project Juntos | 0.647975 |
| 6-month intervals | 0.471343 |
|
CLICK HERE |
| 10107 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH-Solid Waste-Workplace Safety and Health Topic |
null |
| lifting materials | 0.397671 |
| occupational diseases | 0.406565 |
| objects | 0.31591 |
| Services Sector | 0.480546 |
| Disposal | 0.318258 |
| Occupational Research Agenda | 0.506048 |
| NAICS | 0.3329 |
| crash | 0.315501 |
| academia | 0.317055 |
| weather | 0.31572 |
| injury | 0.315685 |
| airborne contaminants | 0.398582 |
| Waste Management | 0.42801 |
| work incidence rate | 0.490332 |
| motor vehicle incident | 0.484482 |
| NORA Sector Councils | 0.516034 |
| local government agencies | 0.487447 |
| private sector | 0.432593 |
| private industry | 0.426926 |
| hydrogen sulfide | 0.400867 |
| service industries | 0.393496 |
| Collection | 0.317987 |
| employees | 0.316567 |
| public sector workers | 0.515241 |
| waste industry workers | 0.51413 |
|
| solid waste industry | 0.90172 |
| partnership program | 0.389713 |
| focused program | 0.392975 |
| vehicles | 0.316053 |
| times | 0.315373 |
| refuse | 0.351716 |
| intervention goals | 0.391733 |
| landfills | 0.320079 |
| diesel exhaust | 0.393732 |
| Labor Statistics | 0.396423 |
| national research | 0.39522 |
| national agenda | 0.412889 |
| Waste Remediation Services | 0.530678 |
| community organizations | 0.392198 |
| Recyclable Materials Collectors | 0.510726 |
| occupational safety | 0.404097 |
| SOC | 0.324144 |
| groups | 0.318 |
| private waste industry | 0.520155 |
| visit https://www.cdc.gov/niosh/nora/sectors/serv/agenda.html | 0.389302 |
| Treatment | 0.317974 |
| mobile equipment | 0.399821 |
| microorganisms | 0.319881 |
| fatalities | 0.324448 |
|
CLICK HERE |
| 10886 |
Centers for Disease Control and Prevention |
Html |
en |
African Network for Influenza Surveillance and Epidemiology (ANISE) |
The African Network for Influenza Surveillance and Epidemiology (ANISE) was founded in 2009 to help scientists share and standardize influenza surveillance methods in Africa. |
| influenza | 0.823984 |
| public health interventions | 0.28238 |
| Army Medical Research | 0.226241 |
| respiratory viruses | 0.39088 |
| Ghana Health Services | 0.233664 |
| academic institutions | 0.203509 |
| African countries | 0.402752 |
| CDC’s Influenza | 0.344043 |
| disease burden estimation | 0.251542 |
| important research studies | 0.267802 |
| anise meeting | 0.90994 |
| Medical Research Unit | 0.41676 |
| Research Unit No. | 0.230612 |
| influenza illness | 0.328744 |
| public health | 0.709864 |
| lesser resourced settings | 0.211447 |
|
| ANISE listserv | 0.364305 |
| public health organizations | 0.357933 |
| Noguchi Memorial Institute | 0.222535 |
| ANISE Network | 0.391021 |
| World Health Organization | 0.23414 |
| influenza vaccines | 0.332154 |
| public health officials | 0.469681 |
| Influenza infection | 0.33805 |
| various participating countries | 0.260475 |
| influenza surveillance | 0.82273 |
| international public health | 0.357983 |
| African Network | 0.314218 |
| South Africa | 0.321982 |
| Institut Pasteur | 0.248019 |
| Severe acute respiratory | 0.272201 |
|
CLICK HERE |
| 12942 |
Centers for Disease Control and Prevention |
Html |
en |
Screening for Colorectal Cancer: Optimizing Quality(CME) |
This free continuing education activity provides guidance and tools for clinicians on the optimal ways to implement screening for colorectal cancer to help ensure that patients receive maximum benefit. |
| CDC-sponsored continuing education | 0.538037 |
| American Association | 0.49242 |
| Dr. Lieberman | 0.552077 |
| Thomas Jefferson University | 0.581492 |
| education activity | 0.505538 |
| U.S. Preventive Services | 0.501974 |
| Nurse Practitioners | 0.488892 |
| AMA PRA Category | 0.575229 |
| nationally recognized experts | 0.49789 |
| Gastrointestinal Endoscopy | 0.497653 |
| International Association | 0.493331 |
| primary care version | 0.506739 |
| primary care providers | 0.509307 |
| Accreditation Council | 0.495276 |
| American Cancer Society | 0.519758 |
| Disease Control | 0.752532 |
| Program ID | 0.494405 |
| Multi-Society Task Force | 0.572093 |
| American Society | 0.495655 |
| colorectal cancer screening | 0.794459 |
| stool blood testing | 0.496038 |
| David Lieberman | 0.506821 |
| health professionals | 0.500038 |
| Center’s Commission | 0.496216 |
|
| Continuing Nursing Education | 0.585372 |
| Cancer Control Officer | 0.518573 |
| Community Medicine | 0.499893 |
| colorectal cancer | 0.95075 |
| colon cancer committee | 0.509268 |
| numerous articles | 0.497568 |
| large clinical research | 0.576352 |
| Continuing Medical Education | 0.584538 |
| AANP CE Standards | 0.575232 |
| public health programs | 0.506834 |
| clinical research studies | 0.576335 |
| Science University | 0.495981 |
| American Nurses | 0.492359 |
| primary care physicians | 0.512834 |
| primary care clinicians | 0.50834 |
| National Colorectal Cancer | 0.56131 |
| primary care provider | 0.499787 |
| Oregon Health | 0.496208 |
| primary care | 0.657769 |
| Governing Board | 0.493377 |
| past president | 0.492384 |
| Credits.â„¢ Physicians | 0.494856 |
| American Gastroenterological Association | 0.579659 |
|
CLICK HERE |
| 13269 |
Centers for Disease Control and Prevention |
Html |
en |
Wes Studi: Seasonal Flu (:60) |
Wes Studi, Hollywood actor, reaches out to tribal communities on how to prevent flu and protect the circle of life. - CDC-TV |
| Hollywood actor | 0.616286 |
| feedback | 0.438327 |
| ways | 0.436719 |
| variety | 0.476012 |
| children | 0.474183 |
| Cherokee tribal member | 0.792288 |
| Wes Studi | 0.687967 |
| safety | 0.475788 |
| different audiences | 0.836861 |
| public health professionals | 0.998154 |
| CDC-TV videos | 0.744428 |
| Mr. Studi | 0.666974 |
| National Center | 0.602681 |
|
| Immunization | 0.451965 |
| Alaska Natives | 0.632967 |
| tribal communities | 0.600906 |
| flu | 0.5175 |
| spread | 0.441444 |
| American Indians | 0.618885 |
| preparedness topics | 0.855167 |
| Respiratory Diseases | 0.611754 |
| comment | 0.440489 |
| risk | 0.437445 |
| circle | 0.436448 |
| Release Date | 0.612162 |
|
CLICK HERE |
| 13548 |
Centers for Disease Control and Prevention |
Html |
en |
World Health Organization Guidelines for Containment ofPoliovirus Following Type-Specific Polio Eradication - Worldwide,2015 |
Nicoletta Previsani, PhD1; Rudolph H. Tangermann, MD1; Graham Tallis1; Hamid S. Jafari, MD1. |
| containment requirements | 0.478777 |
| GAPIII containment criteria | 0.399426 |
| polioviruses | 0.588109 |
| polio eradication | 0.368175 |
| type-specific containment | 0.341665 |
| certified essential poliovirus | 0.329683 |
| oral poliovirus vaccine | 0.316441 |
| OPV/Sabin polioviruses | 0.361099 |
| essential poliovirus facility | 0.323815 |
| Phase IIb | 0.367689 |
| national authorities | 0.47931 |
| national certification | 0.372071 |
| Phase IIa | 0.366025 |
| WPV2 containment provisions | 0.413537 |
| poliovirus diagnostic laboratories | 0.331215 |
| Final poliovirus containment | 0.568559 |
| poliovirus facilities handling | 0.318141 |
| containment | 0.941312 |
| live polioviruses | 0.324703 |
| GAPIII containment requirements | 0.400964 |
| global readiness | 0.374163 |
| containment period | 0.345226 |
| containment certification | 0.33924 |
| containment best practices | 0.420701 |
|
| certified essential facilities | 0.326428 |
| poliovirus containment | 0.648927 |
| appropriate containment | 0.37762 |
| WPV | 0.496182 |
| global bOPV cessation | 0.479458 |
| essential facilities worldwide | 0.320869 |
| WPV eradication | 0.473569 |
| phase | 0.601639 |
| containment procedures | 0.341745 |
| global containment standards | 0.4293 |
| World Health Organization | 0.361324 |
| Endgame Plan | 0.403096 |
| vaccine production facilities | 0.645505 |
| World Health Assembly | 0.363879 |
| essential laboratory | 0.40627 |
| essential poliovirus facilities | 0.789233 |
| poliovirus containment activities | 0.471578 |
| materials | 0.361077 |
| final containment | 0.765614 |
| WPV transmission | 0.316885 |
| production facilities handling | 0.370625 |
| essential facilities | 0.4652 |
| poliovirus containment measures | 0.444285 |
|
CLICK HERE |
| 14318 |
Centers for Disease Control and Prevention |
Image |
null |
Improvised Nuclear Device (IND) | Infographic |
null |
|
|
CLICK HERE |